Format
Sort by
Items per page

Send to

Choose Destination

Best matches for NK cell neoplasias:

Targeting NK-cell checkpoints for cancer immunotherapy. Muntasell A et al. Curr Opin Immunol. (2017)

NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy. Suck G et al. Cancer Immunol Immunother. (2016)

Control of NK Cell Activation by Immune Checkpoint Molecules. Beldi-Ferchiou A et al. Int J Mol Sci. (2017)

Search results

Items: 1 to 20 of 22305

1.

What we should know about natural killer/T-cell lymphomas.

Xiong J, Zhao W.

Hematol Oncol. 2019 Jun;37 Suppl 1:75-81. doi: 10.1002/hon.2588. Review.

PMID:
31187536
2.

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.

Thura M, Al-Aidaroos AQ, Gupta A, Chee CE, Lee SC, Hui KM, Li J, Guan YK, Yong WP, So J, Chng WJ, Ng CH, Zhou J, Wang LZ, Yuen JSP, Ho HSS, Yi SM, Chiong E, Choo SP, Ngeow J, Ng MCH, Chua C, Yeo ESA, Tan IBH, Sng JXE, Tan NYZ, Thiery JP, Goh BC, Zeng Q.

Nat Commun. 2019 Jun 6;10(1):2484. doi: 10.1038/s41467-019-10127-x.

3.

[Mature T- and NK-cell lymphomas].

Yoshimitsu M.

Rinsho Ketsueki. 2019;60(5):441-446. doi: 10.11406/rinketsu.60.441. Japanese.

PMID:
31168011
4.

Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition.

Pereira BI, Devine OP, Vukmanovic-Stejic M, Chambers ES, Subramanian P, Patel N, Virasami A, Sebire NJ, Kinsler V, Valdovinos A, LeSaux CJ, Passos JF, Antoniou A, Rustin MHA, Campisi J, Akbar AN.

Nat Commun. 2019 Jun 3;10(1):2387. doi: 10.1038/s41467-019-10335-5.

5.

[The analysis of peripheral blood T lymphocyte subsets in patients with colorectal cancer: a single center cross-section study].

Xiao TX, Zhang GN, Qiu ZF, Xing CG, Li TS.

Zhonghua Nei Ke Za Zhi. 2019 Jun 1;58(6):453-455. doi: 10.3760/cma.j.issn.0578-1426.2019.06.011. Chinese.

PMID:
31159526
6.

Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.

Liu F, Zheng JP, Wang L, Zhao DH, Li MY, Wang YM, Liu Y, Ma J, Zeng NY, Liu HX, Liang R, Guo SP, Wang Z, Yan QG.

Am J Clin Pathol. 2019 May 29. pii: aqz041. doi: 10.1093/ajcp/aqz041. [Epub ahead of print]

PMID:
31140551
7.

[Ocular natural killer/T cell lymphoma: a clinicopathologic analysis].

Bi YW, Wang SY, Qian J, Yuan YF, Li XQ, Zhu XZ.

Zhonghua Yan Ke Za Zhi. 2019 May 11;55(5):374-380. doi: 10.3760/cma.j.issn.0412-4081.2019.05.012. Chinese.

PMID:
31137150
8.

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.

Maurer B, Nivarthi H, Wingelhofer B, Pham HTT, Schlederer M, Suske T, Grausenburger R, Schiefer AI, Prchal-Murphy M, Chen D, Winkler S, Merkel O, Kornauth C, Hofbauer M, Hochgatterer B, Hoermann G, Hoelbl-Kovacic A, Prochazkova J, Lobello C, Cumaraswamy AA, Latzka J, Kitzwögerer M, Chott A, Janikova A, Pospíšilova Š, Loizou JI, Kubicek S, Valent P, Kolbe T, Grebien F, Kenner L, Gunning PT, Kralovics R, Herling M, Müller M, Rülicke T, Sexl V, Moriggl R.

Haematologica. 2019 May 23. pii: haematol.2019.216986. doi: 10.3324/haematol.2019.216986. [Epub ahead of print]

9.

Combined strategies for tumor immunotherapy with nanoparticles.

Savitsky K, Yu X.

Clin Transl Oncol. 2019 May 4. doi: 10.1007/s12094-019-02081-3. [Epub ahead of print] Review.

PMID:
31055713
10.

Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.

Krijgsman D, de Vries NL, Skovbo A, Andersen MN, Swets M, Bastiaannet E, Vahrmeijer AL, van de Velde CJH, Heemskerk MHM, Hokland M, Kuppen PJK.

Cancer Immunol Immunother. 2019 Jun;68(6):1011-1024. doi: 10.1007/s00262-019-02343-7. Epub 2019 May 3.

11.

Primary nasal diffuse large B-cell lymphoma with synchronous pulmonary involvement: A case report.

Hao S, Sun Y, Hu C, Zhi Y, Xiao H, Li Y.

Medicine (Baltimore). 2019 Apr;98(17):e15439. doi: 10.1097/MD.0000000000015439.

12.

Innate Immune Protein Tag7 Stimulates the Appearance of Cytotoxic NK Cells after Incubation with Lymphocytes.

Sharapova TN, Romanova EA, Sashchenko LP, Gnuchev NV, Yashin DV.

Dokl Biochem Biophys. 2019 May;484(1):92-94. doi: 10.1134/S1607672919010253. Epub 2019 Apr 22.

PMID:
31012024
13.

[Recent Advances in Immunotherapy for Acute Myeloid Leukemia --Review].

Xu B, Xiao Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Apr;27(2):633-636. doi: 10.19746/j.cnki.issn1009-2137.2019.02.053. Review. Chinese.

PMID:
30998183
14.

[Exploration of the Role of Tumor Suppressor Genes Foxo1 and PTEN in the Tumorigenesis of Mouse Natural Killer-Cell Lymphoma].

Jiang Y, Liao HY, Yang QS, Chen Y, Hu YN, Yuan SZ, Su SH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Apr;27(2):439-444. doi: 10.19746/j.cnki.issn.1009-2137.2019.02.021. Chinese.

PMID:
30998151
15.

[Detection and Analysis of T Lymphocyte Subsets and B Lymphocytes in Patients with Acute Leukemia].

Cheng J, Ma HZ, Zhang H.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Apr;27(2):327-330. doi: 10.19746/j.cnki.issn.1009-2137.2019.02.003. Chinese.

PMID:
30998133
16.

Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-γ-associated JAK-STAT pathway.

Xue W, Li W, Zhang T, Li Z, Wang Y, Qiu Y, Wang Y, Chen C, Fu D, Zhang M.

Onco Targets Ther. 2019 Mar 19;12:2079-2088. doi: 10.2147/OTT.S187280. eCollection 2019.

17.

Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model.

Chen M, Xu M, Zhu C, Wang H, Zhao Q, Zhou F.

Cancer Immunol Immunother. 2019 Jun;68(6):961-971. doi: 10.1007/s00262-019-02337-5. Epub 2019 Apr 6.

PMID:
30955067
18.

Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy.

Sanchez-Correa B, Lopez-Sejas N, Duran E, Labella F, Alonso C, Solana R, Tarazona R.

Cancer Immunol Immunother. 2019 May;68(5):861-870. doi: 10.1007/s00262-019-02336-6. Epub 2019 Apr 5. Review.

PMID:
30953117
19.

Central Nervous System Involvement of Natural Killer and T Cell Neoplasms.

Aaroe AE, Nevel KS.

Curr Oncol Rep. 2019 Mar 27;21(5):40. doi: 10.1007/s11912-019-0794-2. Review.

PMID:
30919085
20.

[Aggressive natural killer cell leukemia: study of a case occurred in Africa and literature review].

Benmoussa A, Khalil K, Boufarissi F, Tazi I.

Pan Afr Med J. 2018 Sep 13;31:28. doi: 10.11604/pamj.2018.31.28.16360. eCollection 2018. Review. French.

Supplemental Content

Loading ...
Support Center